Brief: Sesen Bio And Carisma Therapeutics Announce Increased Special Cash Dividend And Stockholder Support For Pending Merger

Carisma Therapeutics

14/02/2023 13:22

Sesen Bio Inc  SESN.O :
    * SESEN BIO AND CARISMA THERAPEUTICS ANNOUNCE INCREASED
SPECIAL
CASH DIVIDEND AND STOCKHOLDER SUPPORT FOR PENDING MERGER
    * SESEN BIO INC - MICHAEL TOROK TO JOIN CARISMA BOARD OF
DIRECTORS
AS ONLY SESEN BIO REPRESENTATIVE
    * SESEN BIO INC - BRADLEY L. RADOFF AND MICHAEL TOROK TO
VOTE
SHARES IN SUPPORT OF TRANSACTION WITH CARISMA
    * SESEN BIO - AMEND MERGER DEAL TO INCREASE EXPECTED SPECIAL
CASH
DIVIDEND TO $75 MILLION & EXTEND CONTINGENT VALUE RIGHT FOR
VICINEUM TO MARCH 31, 2027

Source text for Eikon:  ID:nBwMJZRya 
Further company coverage:  SESN.O